Displaying 69 Munich Biotech companies
 Filter
City
Country
Stage
Business Model
Industry
Clear All
Export
Munich Germany Biotech All business models
company score funding investors employees industries biz model city contact
Tubulis

Developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases.
68
$139M · Series B Nextech Invest, EQT Life Sciences, Andera Partners 11 to 50 Health Tech, Biotech, Deep Tech B2B Munich, Germany •••••••••••@tubulis.com
CatalYm HIRING

Innovative immunotherapies developer for cancer patients.
54
$150M · Series D Brandon Capital, Bioqube Ventures, Forbion Capital Partners 11 to 50 Health Tech, Biotech B2B Munich, Germany •••••••••••@catalym.com
Bind-X

Manufacturer of sustainable biological binding of materials.
50
$10M · Series B HG Ventures, High-Tech Gründerfonds 11 to 50 Biotech, Deep Tech B2B Munich, Germany •••••••••••@bind-x.com
Floy

AI platform for radiology diagnostics.
50
$5M · Seed xdeck, 10x Founders 11 to 50 Health Tech, Biotech Munich, Germany •••••••••••@floy.com
AMSilk

Developer of bio-fabricated silk protein materials.
50
$27M · Series C Novo A/S 11 to 50 Health Tech, Biotech, Manufacturing B2B Munich, Germany •••••••••••@amsilk.com
HMNC Brain Health

Pioneer in precision medicine for psychiatry based in Munich.
43
$10M ALSTIN Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Munich, Germany •••••••••••@hmnc-brainhealth.com
Ryver

AI-powered radiology diagnostics platform.
43
$1M · Pre Seed Fund F, Bayern Kapital, Nina Capital 1 to 10 Health Tech, Biotech B2B, SaaS Munich, Germany •••••••••••@ryver.ai
InsempraJUST ADDED HIRING

Advanced bio-based ingredients manufacturer.
43
$15M · Seed EQT Ventures, Possible Ventures, Inventures SA 11 to 50 Biotech, Manufacturing B2B Munich, Germany •••••••••••@insempra.bio
IRUBIS

Platform specializing in mid-infrared spectroscopy for bioprocessing and biotechnological solutions.
39
$3M · Seed High-Tech Gründerfonds, Verve Ventures 11 to 50 Health Tech, Biotech, Manufacturing, Future of Work B2B Munich, Germany •••••••••••@irubis.com
Sanvivo

Platform for pharmacies to sell medication online.
34
$500k · Pre Seed Y Combinator 1 to 10 Health Tech, Biotech B2C, Marketplace Munich, Germany •••••••••••@sanvivo.eu
Climedo

Platform for clinical validation and product surveillance of medical devices and pharmaceutical products.
34
$1M · Pre Seed Nauta Capital 51 to 100 Health Tech, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Munich, Germany •••••••••••@climedo.de
Invitris

Protein-based drugs.
34
$500k · Pre Seed Y Combinator 1 to 10 Health Tech, Biotech Munich, Germany •••••••••••@invitris.com
smartbax

Next-gen antibiotics.
34
$1M · Seed High-Tech Gründerfonds 1 to 10 Health Tech, Biotech Munich, Germany •••••••••••@smartbax.de
Temedica

Crafting the future of personal health.
31
$26M 51 to 100 Health Tech, Hardware, Biotech, Data and Analytics Munich, Germany •••••••••••@temedica.com
Atai Life Sciences

Platform for developing new mental health treatments for unmet medical needs.
31
$45M 101 to 250 Health Tech, Biotech, Deep Tech, Data and Analytics B2B Munich, Germany •••••••••••@atai.life
Molab

Biotechnology firm leveraging AI to expedite molecule creation.
29
N/A Picus Capital 1 to 10 AI, Biotech, Pharma, Business Intelligence B2B Munich, Germany •••••••••••@molab.ai
AATec Medical

Product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases.
28
$2M · Seed 1 to 10 Health Tech, Biotech B2C Munich, Germany •••••••••••@aatec-medical.com
mbiomics

Bacterial profiling and microbiome analysis.
28
$14M · Series A 51 to 100 Biotech Munich, Germany •••••••••••@mbiomics.com
Ethris HIRING

mRNA therapeutics and LNP delivery.
28
$5M · Series A Bill & Melinda Gates Foundation 101 to 250 Health Tech, Biotech B2B Munich, Germany •••••••••••@ethris.com
Saffe

Face recognition for payments and financial services.
15
N/A 11 to 50 AI, Biotech Munich, Germany •••••••••••@saffe.co
ITMJUST ADDED HIRING

Developer of radiomolecular precision therapeutics and diagnostics for treatment of tumors.
1
$205M · Series D Qatar Investment Authority, BlackRock, Temasek Holdings 501 to 1000 Health Tech, Biotech Munich, Germany •••••••••••@itm-radiopharma.com